IXSBF
Price:
$0.0001
Market Cap:
$17.51K
InNexus Biotechnology, Inc., a development stage company, engages in the commercialization of monoclonal antibodies based on its Dynamic Cross Linking (DXL) technology. Its DXL technology seeks to improve the therapeutic potency of existing monoclonal antibody products by increasing the binding to target antigen, enhancing antibody effector functions, and installing new properties into antibodies. The company's products in pipeline include DXL625, a monoclonal antibody in late stage pre-clinical development produced with enhanced binding kinetics and effector functions for the treatment of B cell non-Hodgkins lymphoma (NHL) and DXLr120, a recombinant DXL anti-CD20 antibody being developed fo...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2005-01-28
Stock Exchange
OTC
Ticker
IXSBF
According to InNexus Biotechnology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.41% compared to the average of -1.68 of the last 4 quarters.
The mean historical PE Ratio of InNexus Biotechnology, Inc. over the last ten years is -5.69. The current -0.01 PE Ratio has changed -82.41% with respect to the historical average. Over the past ten years (40 quarters), IXSBF's PE Ratio was at its highest in in the September 2003 quarter at 20.87. The PE Ratio was at its lowest in in the September 2001 quarter at -20.82.
Average
-5.69
Median
-3.55
Minimum
-11.71
Maximum
-0.38
Discovering the peaks and valleys of InNexus Biotechnology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 95.76%
Maximum Annual PE Ratio = -0.38
Minimum Annual Increase = -82.15%
Minimum Annual PE Ratio = -11.71
| Year | PE Ratio | Change |
|---|---|---|
| 2010 | -0.38 | -69.48% |
| 2009 | -1.25 | -45.47% |
| 2008 | -2.30 | -23.38% |
| 2007 | -3.00 | -26.61% |
| 2006 | -4.09 | 95.76% |
| 2005 | -2.09 | -82.15% |
| 2004 | -11.71 | 0.80% |
| 2003 | -11.62 | 14.14% |
| 2002 | -10.18 | -0.49% |
| 2001 | -10.23 | -72.36% |
The current PE Ratio of InNexus Biotechnology, Inc. (IXSBF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.31
5-year avg
-2.21
10-year avg
-5.69
InNexus Biotechnology, Inc.’s PE Ratio is less than Biomagnetics Diagnostics Corp. (-0.00), greater than Wellness Center USA, Inc. (-0.02), greater than Vaxxinity, Inc. (-11.11), less than PaxMedica, Inc. Common Stock (-0.00), less than NovAccess Global Inc. (-0.00), less than NanoLogix, Inc. (-0.01), greater than ORHub, Inc. (-0.01), less than SmileDirectClub, Inc. (-0.00), less than VIA Pharmaceuticals, Inc. (-0.00), greater than Strategic Partners A/S (-1504.91),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $1.26K | |
| -0.02 | $13.04K | |
| -11.11 | $633.90K | |
| -0.00 | $12.56K | |
| -0.00 | $6.19K | |
| -0.01 | $11.96K | |
| -0.01 | $27.50K | |
| -0.00 | $13.39K | |
| -0.00 | $10.28K | |
| -1504.91 | $3.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InNexus Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like InNexus Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is InNexus Biotechnology, Inc.'s PE Ratio?
How is the PE Ratio calculated for InNexus Biotechnology, Inc. (IXSBF)?
What is the highest PE Ratio for InNexus Biotechnology, Inc. (IXSBF)?
What is the 3-year average PE Ratio for InNexus Biotechnology, Inc. (IXSBF)?
What is the 5-year average PE Ratio for InNexus Biotechnology, Inc. (IXSBF)?
How does the current PE Ratio for InNexus Biotechnology, Inc. (IXSBF) compare to its historical average?